RBM15 Drives Non-Small Cell Lung Cancer Immune Evasion via RNA Methylation
Researchers have demonstrated that the RNA methyltransferase subunit RBM15 drives immune evasion in non-small cell lung cancer cell models by ...
Researchers have demonstrated that the RNA methyltransferase subunit RBM15 drives immune evasion in non-small cell lung cancer cell models by ...
A review highlights how the tumor microenvironment and PD-L1 shape immune checkpoint combination therapy in triple-negative breast cancer.
Single-cell and laboratory analyses identify HMGA1 as a candidate regulator connecting lactate metabolism to regulatory T cell-associated immune responses in ...
A comprehensive narrative review published in Clinical and Experimental Medicine has synthesized the experimental and clinical evidence examining whether the ...
A review in Discover Oncology reports that no m6A RNA modification axis has achieved site-resolved validation in immune-competent orthotopic bladder ...
A multi-database and laboratory evaluation identifies immune checkpoint CD112 as an independent prognostic biomarker linked to reduced survival in cervical ...
Downregulation of the transcription factor RFX2 promotes immune escape and tumor progression in lung adenocarcinoma by suppressing RASSF1 and reducing ...
A systematic review and meta-analysis of lung cancer immunotherapy trials finds lower peripheral but higher central neurological immune-related adverse event ...
A review in Cancer Cell International details how hypoxia-inducible factors drive immune evasion in head and neck squamous cell carcinoma, ...
A new study in Frontiers in Oncology reveals that PD-L1 deletion or blockade in macrophages consistently reduces surface levels of ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine